Stemline Therapeutics, Inc.

$229.5M revenue • 519 employees • 750 Lexington Ave, New York, NY, 10022, United States

Last Updated Feb 19, 2026

Company Overview

Company Name

Stemline Therapeutics, Inc.

Address

750 Lexington Ave, New York, NY, 10022, United States

Approx. Annual Revenue

$229.5M

Employees

519

Established

2000

About Stemline Therapeutics, Inc.

Stemline Therapeutics is a biopharmaceutical company based in the United States. The company is focused on developing innovative oncology therapies, with two approved products, Elzonris and Orserdu, used for the treatment of specific types of cancer. Stemline Therapeutics is part of the Menarini Group, a leading international pharmaceutical and diagnostics company.

Frequently Asked Questions about Stemline Therapeutics, Inc.

Technologies Used

Key Decision Makers

Kenitra Burton General Manager
Siva Tallavajhala Director
LinkedIn
Josh Goffin Sr. Diagnostic Manager - Strategic Partnerships
LinkedIn